/

KHRNF

KHIRON LIFE SCIENCES CORPPre-market

0.0000100.00 0.00%USD

OTC Markets OTCPK · as of Oct 12, 16:00 ET · 15m delay

Open

0.000001

Prev close

0.000010

Day range

0.0000010.000001

52-week range

0.0000010.000010

Volume

15.04K

Mkt cap

2.32K

P/E ttm

—

Fwd P/E

—

EPS ttm

0.000000

Div yield

0.00%

Earnings

—

From 52w high

0.00%

Price Chart

Yahoo Finance · delayed

KHRNFOct 13, 2026O 0.0000H 0.0000L 0.0000C 0.00000.0000 (0.00%)

SMA 500.0000
SMA 2000.0000

1Y change 0.00% since Oct 13, 2025 close539 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

KHRNF KHIRON LIFE SCIENCES CORP · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: 0.00%
1 month: 0.00%
3 months: 0.00%
6 months: 0.00%
Year to date: 0.00%
1 year: 0.00%

Valuation & ownership

Market cap: 2.32K
Enterprise value: 626.22K
P/E (ttm): —
Forward P/E: —
PEG ratio: —
Price / book: 0.00
Price / sales (ttm): 0.00
EV / EBITDA: -0.04
EPS (ttm): -0.000000
EPS (forward): —
Beta (5y monthly): 20.72
Dividend yield: 0.00%
Payout ratio: 0.00%
Shares outstanding: 232.41M
Float: 204.94M
Short % of float: —
Short ratio (days): —
Held by insiders: 0.00%
Held by institutions: 0.21%
Avg volume (3m): 0
50-day average: 0.000010
200-day average: 0.000010
52-week change: 0.00%
S&P 500 52-week: +17.03%

Technicals (daily)

RSI (14): oversold 0.0
vs 50-day SMA: 0.00%
vs 200-day SMA: 0.00%
50 / 200-day trend: ▼ 50 below 200
MACD vs signal: ▲ above
ATR (14) % of price: 0.00%
Realised vol (20d, ann.): 0.0%
From 52-week high: 0.00%
From 52-week low: 0.00%

ANR

Analyst Consensus

No analyst coverage for this instrument.

Financial Snapshot

Full statements →trailing twelve months

Revenue (ttm): 16.14M
Revenue growth (yoy): −3.80%
Earnings growth (yoy): —
Gross margin: 41.34%
Operating margin: -103.55%
Profit margin: -190.00%

DES

About KHIRON LIFE SCIENCES CORP

Yahoo Finance profile

Khiron Life Sciences Corp. operates as a medical cannabis company in Latin America and Europe. It engages in the cultivation, production, distribution, and export of tetrahydrocannabinol medical cannabis products. The company is also involved in the operation of health centers under the Zerenia and Dr. Zerenia brand names; and provision of medical education and training programs for health professionals. It sells its products in Colombia, Peru, Germany, the United Kingdom, Brazil, Uruguay, and Mexico. The company is headquartered in Bogota, Colombia.

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Headquarters: Bogota, Colombia
Website: khiron.ca
Officers: Dr. Alvaro Francisco Torres Co-Founder, CEO & Director
Ms. Franziska Katterbach President of Khiron Europe
Mr. Swapan Kakumanu ACA, ACWA, CGA Corporate Secretary
Mr. Michael John O'Connor MA Chief Financial Officer

SEAS

Seasonality · KHRNF

2018–2026 · monthly returns

Strongest month Jan +84.44%Weakest month Jun −25.82%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0%
2025	0.0	-90.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	−90.0%
2024	333.3	-30.8	0.0	0.0	0.0	-98.9	0.0	0.0	0.0	0.0	0.0	0.0	−96.7%
2023	180.5	-39.9	-48.6	2.2	-11.0	-39.2	-26.6	-6.5	-9.9	-2.4	-8.3	-72.7	−92.8%
2022	0.6	-1.8	23.6	-6.2	-25.8	-33.4	-4.4	7.1	-24.1	6.2	-18.1	-34.2	−74.8%
2021	-5.4	57.1	1.2	2.5	-15.2	-8.5	-31.0	-5.8	-4.4	-7.9	-20.0	1.9	−44.3%
2020	-13.5	-30.9	-16.2	9.4	22.5	-25.6	-7.4	7.2	-16.1	-8.8	16.4	-16.8	−63.3%
2019	95.5	19.1	12.1	-8.5	-31.8	-4.6	-13.2	-28.2	-17.0	-15.9	-2.2	9.0	−28.0%
2018						3.6	-25.6	17.3	79.4	-35.9	21.7	0.0	+26.6%

INSD

Insider Activity · KHRNF

Market-wide insider buying →Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

0 shares

Sells, 6 months

— shares

Net shares

Net change in insider shares

—

Date	Insider	Transaction	Shares	Value
Sep 5, 2022	Echeverry (Juan Carlos)Director of Issuer	—	120K	—
Jun 9, 2022	Yanez (Alvaro Josue)Director of Issuer	Acquisition or disposition under a prospectus at price 0.12 per share.	100K	$11.70K
Jun 9, 2022	Torres (Alvaro Francisco)Director of Issuer	Acquisition or disposition under a prospectus at price 0.12 per share.	400K	$46.80K
Jun 9, 2022	Naprawa (Chris)Director of Issuer	Acquisition or disposition under a prospectus at price 0.12 per share.	1.00M	$117.00K
Jun 9, 2022	Katterbach (Franziska Maximiliane Maria Therese)Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)	Acquisition or disposition under a prospectus at price 0.12 per share.	400K	$46.80K
Jun 9, 2022	Kakumanu (Swapan)Senior Officer of Issuer	Acquisition or disposition under a purchase/ownership plan at price 0.12 per share.	135K	$15.79K
Jan 3, 2022	Naprawa (Chris)Director of Issuer	Acquisition or disposition in the public market at price 0.19 per share.	50K	$9.45K
Dec 22, 2021	Naprawa (Chris)Director of Issuer	Acquisition or disposition in the public market at price 0.17 per share.	150K	$25.20K
Dec 21, 2021	Torres (Alvaro Francisco)Director of Issuer	Acquisition or disposition in the public market at price 0.16 per share.	240K	$38.40K
Dec 2, 2021	Echeverry (Juan Carlos)Director of Issuer	Acquisition or disposition in the public market at price 0.16 per share.	120K	$18.72K

KHRNF

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

KHRNF

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About KHIRON LIFE SCIENCES CORP

Seasonality · KHRNF

Insider Activity · KHRNF

Congress Trades · KHRNF

Investors Holding KHRNF

Investors Holding KHRNF

Congress Trades · KHRNF

Insider Activity · KHRNF

Seasonality · KHRNF

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About KHIRON LIFE SCIENCES CORP

Earnings & Dividends

News